Schaper Benz & Wise Investment Counsel Inc. WI Cuts Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Schaper Benz & Wise Investment Counsel Inc. WI decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 224,214 shares of the pharmacy operator’s stock after selling 12,026 shares during the quarter. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Walgreens Boots Alliance were worth $2,009,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. First Trust Direct Indexing L.P. raised its position in shares of Walgreens Boots Alliance by 1.9% during the 1st quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock worth $696,000 after acquiring an additional 597 shares in the last quarter. Buckley Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 2.1% during the 1st quarter. Buckley Wealth Management LLC now owns 37,335 shares of the pharmacy operator’s stock worth $810,000 after buying an additional 785 shares during the last quarter. FinTrust Capital Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 60.4% during the 1st quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock worth $46,000 after buying an additional 802 shares during the last quarter. True Vision MN LLC boosted its holdings in shares of Walgreens Boots Alliance by 3.3% in the 1st quarter. True Vision MN LLC now owns 26,137 shares of the pharmacy operator’s stock valued at $567,000 after buying an additional 830 shares in the last quarter. Finally, Redwood Investment Management LLC grew its position in shares of Walgreens Boots Alliance by 0.9% in the 1st quarter. Redwood Investment Management LLC now owns 99,661 shares of the pharmacy operator’s stock valued at $2,162,000 after buying an additional 850 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. TD Cowen reduced their price target on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. UBS Group boosted their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday. Barclays raised their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday. Truist Financial cut their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Finally, Evercore ISI increased their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $13.38.

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $10.79 on Friday. The business’s 50 day moving average is $9.41 and its two-hundred day moving average is $13.10. Walgreens Boots Alliance, Inc. has a 12-month low of $8.22 and a 12-month high of $27.05. The company has a current ratio of 0.68, a quick ratio of 0.31 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same quarter in the prior year, the company posted $0.67 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 5.9% on a year-over-year basis. As a group, analysts expect that Walgreens Boots Alliance, Inc. will post 1.57 earnings per share for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.